Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) EPS (Basic): 2020-2025

Historic EPS (Basic) for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$0.34.

  • Insight Molecular Diagnostics' EPS (Basic) rose 65.31% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.90, marking a year-over-year increase of 34.53%. This contributed to the annual value of -$3.63 for FY2024, which is 925.17% down from last year.
  • Insight Molecular Diagnostics' EPS (Basic) amounted to -$0.34 in Q3 2025, which was down 13.33% from -$0.30 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' EPS (Basic) ranged from a high of $4.56 in Q4 2022 and a low of -$2.00 during Q4 2024.
  • Its 3-year average for EPS (Basic) is -$0.76, with a median of -$0.81 in 2023.
  • Examining YoY changes over the last 5 years, Insight Molecular Diagnostics' EPS (Basic) showed a top increase of 1,240.00% in 2022 and a maximum decrease of 1,333.33% in 2022.
  • Over the past 5 years, Insight Molecular Diagnostics' EPS (Basic) (Quarterly) stood at -$0.40 in 2021, then surged by 1,240.00% to $4.56 in 2022, then slumped by 142.89% to -$1.96 in 2023, then dropped by 2.14% to -$2.00 in 2024, then skyrocketed by 65.31% to -$0.34 in 2025.
  • Its last three reported values are -$0.34 in Q3 2025, -$0.30 for Q2 2025, and -$0.26 during Q1 2025.